InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	TOTAL BRAIN LIMITED (TTB)
ISIN:	AU0000032435
Date of Listing:	28 August 2001
Date of Delisting:	01 March 2023
Former Names:

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 01 March 2023.

Legal Status: (updated monthly)

ACN: 094 069 682ABN: 24 094 069 682
Registration Date: 08 August 2000

This entity was placed in liquidation on 01 March 2023.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

An administrator or liquidator has declared during tax year 2023-24 that they have reasonable grounds to believe there is no likelihood that shareholders will receive any further distribution for their securities. You are therefore entitled to crystallise a capital loss in that tax year. If you did not do so, you may seek to re-open that year’s assessment but anyway should seek professional advice as to how best to proceed.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

TOTAL BRAIN LIMITED(TTB)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
BRAIN RESOURCE LIMITED	07/05/2008	03/12/2018
BRAIN RESOURCE COMPANY LIMITED (THE)		07/05/2008

Shareholder links

Our website ranking of TTB:

(3 out of 5)

COMPANY WEBSITE:

TTB website

TTB email

TTB investorRelations

REGISTRY:

Level 8, 210 George Street, Sydney NSW 2000

Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000032435

Address: Suite 9, 89-97 Jones Street, Ultimo NSW 2007
Tel: (02) 9213 6666 Fax: (02) 9211 2710

Date first listed: 28/08/2001
Company Secretary:
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Commercialising brain function analysis

News & Events

Expand this box to read and print

The liquidator reports on their activities during the creditors' voluntary winding-up of the company.	02/07/2024
a loss declaration has been issued and the capital loss can therefore be claimed in the financial year the declaration is issued (this declaration was issued today)	07/06/2024
delisted at entity's request under Listing Rule 17.11	01/03/2023
we understand that following the purchase of the TTB business by SonderMind, shareholders approved the voluntary winding up of the company and its delisting from ASX (the company made a capital return of $0.0475 a share on 14 Feb 2023 with the possibility of a further return following the liquidation of the company)	01/03/2023
The securities of Total Brain Limited will be suspended from quotation at the close of trading on 28 February 2023 under Listing Rule 17.2, following shareholder approval at its Extraordinary General Meeting on 1 February 2023 to remove TTB from the Official List.	28/02/2023
The suspension of trading in the securities of Total Brain Limited will be lifted immediately following the release by TTB of an announcement regarding the sale of its main undertaking.	05/08/2022
TTB enters into binding agreement with SonderMind to purchase the TTB business through a sale of assets. Purchase price is US$10 million, less adjustments and liabilities, including the value of assumed employee leave entitlements of any transferring employees, any debt funding provided by or on behalf of SonderMind to fund the Company's working capital requirements and an agreed adjustment on account of certain tax liabilities. Transaction is subject to a number of conditions, including TTB shareholder approval. The TTB Board unanimously recommends that shareholders vote in favour of the transaction, subject to the independent expert opining the transaction is in the best interests of shareholders and in the absence of a Superior Proposal. Post-completion of the transaction, TTB intends to return funds to shareholders via a buy-back facility and commence a winding up.	05/08/2022
The securities of Total Brain Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of TTB, pending the release of an announcement regarding a significant transaction.	03/08/2022
we understand that on or about this date the company consolidated its shares 1 for 10	23/01/2020
The suspension of trading in the securities of Total Brain Limited will be lifted immediately, following the release by TTB of an announcement regarding the completion of its capital raising.	08/11/2019
Total Brain raises A$14 million in an upsized placement. Placement received significant institutional support from 10 new and existing investors. Capital secured to further advance Total Brain's sales and marketing initiatives, product development and deployment and support other working capital requirements.	08/11/2019
The securities of Total Brain Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of TTB, pending the release of an announcement regarding a capital raising.	07/11/2019
name changed from Brain Resource Limited	03/12/2018

The liquidator reports on their activities during the creditors' voluntary winding-up of the company.	02/07/2024
a loss declaration has been issued and the capital loss can therefore be claimed in the financial year the declaration is issued (this declaration was issued today)	07/06/2024
delisted at entity's request under Listing Rule 17.11	01/03/2023
we understand that following the purchase of the TTB business by SonderMind, shareholders approved the voluntary winding up of the company and its delisting from ASX (the company made a capital return of $0.0475 a share on 14 Feb 2023 with the possibility of a further return following the liquidation of the company)	01/03/2023
The securities of Total Brain Limited will be suspended from quotation at the close of trading on 28 February 2023 under Listing Rule 17.2, following shareholder approval at its Extraordinary General Meeting on 1 February 2023 to remove TTB from the Official List.	28/02/2023
The suspension of trading in the securities of Total Brain Limited will be lifted immediately following the release by TTB of an announcement regarding the sale of its main undertaking.	05/08/2022
TTB enters into binding agreement with SonderMind to purchase the TTB business through a sale of assets. Purchase price is US$10 million, less adjustments and liabilities, including the value of assumed employee leave entitlements of any transferring employees, any debt funding provided by or on behalf of SonderMind to fund the Company's working capital requirements and an agreed adjustment on account of certain tax liabilities. Transaction is subject to a number of conditions, including TTB shareholder approval. The TTB Board unanimously recommends that shareholders vote in favour of the transaction, subject to the independent expert opining the transaction is in the best interests of shareholders and in the absence of a Superior Proposal. Post-completion of the transaction, TTB intends to return funds to shareholders via a buy-back facility and commence a winding up.	05/08/2022
The securities of Total Brain Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of TTB, pending the release of an announcement regarding a significant transaction.	03/08/2022
we understand that on or about this date the company consolidated its shares 1 for 10	23/01/2020
The suspension of trading in the securities of Total Brain Limited will be lifted immediately, following the release by TTB of an announcement regarding the completion of its capital raising.	08/11/2019
Total Brain raises A$14 million in an upsized placement. Placement received significant institutional support from 10 new and existing investors. Capital secured to further advance Total Brain's sales and marketing initiatives, product development and deployment and support other working capital requirements.	08/11/2019
The securities of Total Brain Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of TTB, pending the release of an announcement regarding a capital raising.	07/11/2019
name changed from Brain Resource Limited	03/12/2018

Your browser may reflect a date of printing in American format.

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
12/02/2019	Matthew Morgan	315,111	$0.027	$8,558.00
19/12/2018	Matthew Morgan	284,320	$0.030	$8,530.00
16/11/2018	Matthew Morgan	134,219	$0.035	$4,698.00
14/03/2018	Matthew Morgan	175,675	$0.050	$8,814.00
13/03/2018	Matthew Morgan	5,001	$0.497	$2,485.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Evian Gordon	Executive Chairman	08/08/2000
Simon Poidevin	President	20/03/2020
Matthew Mund	Interim CEO, COO	03/08/2017
Nestor Hinzack	Non Exec Director	16/05/2001
David Torrible	Non Exec Director	01/06/2019
Matthew Morgan	Non Exec Director	01/03/2016
Nathan Jong	Company Secretary
Phillip Hains	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.